4NJL

Crystal structure of middle east respiratory syndrome coronavirus S2 protein fusion core

4NJL の概要

• エントリーDOI: 10.2210/pdb4njl/pdb
• 分子名称: S protein, TRIETHYLENE GLYCOL (3 entities in total)
• 機能のキーワード: six-helix-bundle, coronavirus, mers-cov, fusion inhibitor, fusion core, viral protein
• 由来する生物種: Middle East respiratory syndrome coronavirus
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 14195.80

構造登録者

Zhu, Y.,Lu, L.,Qin, L.,Ye, S.,Jiang, S.,Zhang, R. (登録日: 2013-11-10, 公開日: 2014-02-19, 最終更新日: 2023-09-20)

主引用文献

Lu, L.,Liu, Q.,Zhu, Y.,Chan, K.H.,Qin, L.,Li, Y.,Wang, Q.,Chan, J.F.,Du, L.,Yu, F.,Ma, C.,Ye, S.,Yuen, K.Y.,Zhang, R.,Jiang, S.
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.
Nat Commun, 5:3067-3067, 2014

PubMed Abstract: A novel human coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), has caused outbreaks of a SARS-like illness with high case fatality rate. The reports of its person-to-person transmission through close contacts have raised a global concern about its pandemic potential. Here we characterize the six-helix bundle fusion core structure of MERS-CoV spike protein S2 subunit by X-ray crystallography and biophysical analysis. We find that two peptides, HR1P and HR2P, spanning residues 998-1039 in HR1 and 1251-1286 in HR2 domains, respectively, can form a stable six-helix bundle fusion core structure, suggesting that MERS-CoV enters into the host cell mainly through membrane fusion mechanism. HR2P can effectively inhibit MERS-CoV replication and its spike protein-mediated cell-cell fusion. Introduction of hydrophilic residues into HR2P results in significant improvement of its stability, solubility and antiviral activity. Therefore, the HR2P analogues have good potential to be further developed into effective viral fusion inhibitors for treating MERS-CoV infection.

PubMed: 24473083
DOI: 10.1038/ncomms4067

実験手法

X-RAY DIFFRACTION (2.3 Å)